SCHEMBL12228490

SCHEMBL12228490

COc1ccc(C(=O)NC(=O)c2ccccc2)c(O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.68
LMNA P02545 4/20 0.68
ALDH1A1 P00352 3/20 0.68
CYP1A2 P05177 2/20 0.68
PGR P06401 2/20 0.68
SLC6A2 P23975 2/20 0.68
CYP2C19 P33261 2/20 0.68
MAPK1 P28482 2/20 0.68
CYP2D6 P10635 1/20 0.68
PDE4A P27815 1/20 0.68
HRH1 P35367 1/20 0.68
HTT P42858 1/20 0.68
SLC6A3 Q01959 1/20 0.68
PDE4D Q08499 1/20 0.68
NPC1 O15118 7/20 0.57
RAB9A P51151 7/20 0.57
CYP3A4 P08684 2/20 0.57
ADORA3 P0DMS8 1/20 0.57
AR P10275 1/20 0.57
CHRM1 P11229 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609315 0.87 APP (0.61) HPGDLMNAALDH1A1CYP1A2PGR
SCHEMBL12228488 0.86 LMNA (0.57) HPGDLMNAALDH1A1CYP1A2PGR
SCHEMBL12228486 0.83 NPC1 (0.60) HPGDLMNAALDH1A1CYP1A2PGR
SCHEMBL12228483 0.82 RAB9A (0.50) HPGDLMNAALDH1A1CYP1A2PGR
SCHEMBL684675 0.82 L3MBTL1 (0.63) HPGDLMNAALDH1A1CYP1A2PGR
SCHEMBL12829252 0.82 HPGD (0.50) HPGDLMNAALDH1A1CYP1A2PGR
Oxybenzone SCHEMBL15551 0.81 HPGD (1.00) HPGDLMNAALDH1A1CYP1A2PGR
Oxybenzone SCHEMBL6674080 0.81 HPGD (1.00) HPGDLMNAALDH1A1CYP1A2PGR
Oxybenzone SCHEMBL5161586 0.81 HPGD (1.00) HPGDLMNAALDH1A1CYP1A2PGR
Oxybenzone SCHEMBL29355332 0.81 HPGD (1.00) HPGDLMNAALDH1A1CYP1A2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044123-B2 Ultraviolet absorber composition and resin composition FUJIFILM CORPORATION (JP) 2011-10-25 US disclosed
US-8044123-B2 Ultraviolet absorber composition and resin composition FUJIFILM CORPORATION (JP) 2011-10-25 US disclosed
US-20110077330-A1 POLYCARBONATE RESIN COMPOSITION CONTAINING TRIAZINE COMPOUND AND MOLDED ARTICLE USING THE SAME FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed
US-20100324181-A1 ULTRAVIOLET ABSORBER COMPOSITION AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-23 US disclosed
US-20100324181-A1 ULTRAVIOLET ABSORBER COMPOSITION AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-23 US disclosed
US-20100311877-A1 NOVEL TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed
US-20100311877-A1 NOVEL TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311877-A1 NOVEL TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION AVPR1B, H1-0, H1-2 HPGD 1070/4885LMNA 1315/4885ALDH1A1 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.